{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:18:56Z","timestamp":1783484336512,"version":"3.55.0"},"reference-count":16,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1507\/endocrj.k09e-263","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T06:07:01Z","timestamp":1292479621000},"page":"439-443","source":"Crossref","is-referenced-by-count":29,"title":["Superior thyroid artery mean peak systolic velocity for the diagnosis of thyrotoxicosis in Japanese patients"],"prefix":"10.1507","volume":"57","author":[{"given":"Toyoyoshi","family":"Uchida","sequence":"first","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kageumi","family":"Takeno","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Goto","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Kanno","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Kubo","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Azuma","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sakai","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Fujitani","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"},{"name":"Center for Therapeutic Innovations in Diabetes, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Hirose","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"},{"name":"Center for Therapeutic Innovations in Diabetes, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuzo","family":"Kawamori","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"},{"name":"Center for Therapeutic Innovations in Diabetes, Juntendo University, Graduate School, Tokyo, Japan"},{"name":"Center for Beta Cell Biology and Regeneration, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Watada","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Metabolism and Endocrinology, Juntendo University, Graduate School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, Mori H, Iwatani Y, Nishi K, Nakatani K, Miyai K (1981) Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves’ disease and destruction-induced thyrotoxicosis. J Clin Endocrinol Metab 53 : 113-116.","DOI":"10.1210\/jcem-53-1-113"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sayama N, Yoshida K, Mori K, Fukazawa H, Hori H, Nakazato N, Tani, Nakagawa Y, Ito S (1998) Measurement of red blood cell zinc concentration with Zn-test kit: discrimination between hyperthyroid Graves’ disease and transient thyrotoxicosis. Endocr J 45 : 767-772.","DOI":"10.1507\/endocrj.45.767"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ralls PW, Mayekawa DS, Lee KP, Colletti PM, Radin DR, Boswell WD, and Halls JM (1988) Color-flow Doppler sonography in Graves disease: “thyroid inferno”. AJR Am J Roentgenol 150 : 781-784.","DOI":"10.2214\/ajr.150.4.781"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Castagnone D, Rivolta R, Rescalli S, Baldini MI, Tozzi R, Cantalamessa L (1996) Color Doppler sonography in Graves’ disease: value in assessing activity of disease and predicting outcome. AJR Am J Roentgenol 166 : 203-207.","DOI":"10.2214\/ajr.166.1.8571877"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bogazzi F, Bartalena L, Brogioni S, Scarcello G, Burelli A, Campomori A, Manetti L, Rossi G, Pinchera A, Martino E (1999) Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves’ hyperthyroidism. J Clin Endocrinol Metab 84 : 499-503.","DOI":"10.1210\/jc.84.2.499"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E (1997) Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7 : 541-545.","DOI":"10.1089\/thy.1997.7.541"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hari Kumar KV, Pasupuleti V, Jayaraman M, Abhyuday V, Rayudu BR, Modi KD (2009) Role of thyroid Doppler in differential diagnosis of thyrotoxicosis. Endocr Pract 15 : 6-9.","DOI":"10.4158\/EP.15.1.6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hodgson KJ, Lazarus JH, Wheeler MH, Woodcock JP, Owen GM, McGregor AM, Hall R (1988) Duplex scan-derived thyroid blood flow in euthyroid and hyperthyroid patients. World J Surg 12 : 470-5.","DOI":"10.1007\/BF01655423"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi A, Bartolozzi C, Pinchera A, Martino E (1995) Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves’ disease from Hashimoto’s thyroiditis. J Endocrinol Invest 18 : 857-861.","DOI":"10.1007\/BF03349833"},{"key":"10","unstructured":"10. Chang DC, Wheeler MH, Woodcock JP, Curley I, Lazarus JR, Fung H, John R, Hall R, McGregor AM (1987) The effect of preoperative Lugol’s iodine on thyroid blood flow in patients with Graves’ hyperthyroidism. Surgery 102 : 1055-1061."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nagura S, Katoh R, Miyagi E, Shibuya M, Kawaoi A (2001) Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density. Hum Pathol 32 : 10-17.","DOI":"10.1053\/hupa.2001.21139"},{"key":"12","unstructured":"12. Iitaka M, Miura S, Yamanaka K, Kawasaki S, Kitahama S, Kawakami Y, Kakinuma S, Oosuga I, Wada S, Katayama S (1998) Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves’ disease and Hashimoto’s thyroiditis. J Clin Endocrinol Metab 83 : 3908-3912."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bogazzi F, Bartalena L, Brogioni S, Burelli A, Manetti L, Tanda ML, Gasperi M, Martino E (1999) Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Eur J Endocrinol 140 : 452-456.","DOI":"10.1530\/eje.0.1400452"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Saleh A, Furst G, Feldkamp J, Godehardt E, Grust A, Modder U (2001) Estimation of antithyroid drug dose in Graves’ disease: value of quantification of thyroid blood flow with color duplex sonography. Ultrasound Med Biol 27 : 1137-1141.","DOI":"10.1016\/S0301-5629(01)00410-0"},{"key":"15","unstructured":"15. Fobbe F, Finke R, Reichenstein E, Schleusener H, Wolf KJ (1989) Appearance of thyroid diseases using colourcoded duplex sonography. Eur J Radiol 9 : 29-31."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Saleh A, Cohnen M, Furst G, Godehardt E, Modder U, Feldkamp J (2002) Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves’ disease and diffuse toxic goiter. Exp Clin Endocrinol Diabetes 110: 32-36.","DOI":"10.1055\/s-2002-19992"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/5\/57_K09E-263\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T19:22:17Z","timestamp":1692732137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/5\/57_K09E-263\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":16,"aliases":["10.1507\/endocrj.k10e-263"],"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k09e-263","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}